BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33597463)

  • 1. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots.
    Molan A; Nosaka K; Hunter M; Wang W
    Trop Biomed; 2019 Dec; 36(4):898-925. PubMed ID: 33597463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The global seroprevalence of Toxoplasma gondii in pigs: A systematic review and meta-analysis.
    Foroutan M; Fakhri Y; Riahi SM; Ebrahimpour S; Namroodi S; Taghipour A; Spotin A; Gamble HR; Rostami A
    Vet Parasitol; 2019 May; 269():42-52. PubMed ID: 31079827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global seroprevalence of Toxoplasma gondii in Camelidae: A systematic review and meta-analysis.
    Maspi N; Nayeri T; Moosazadeh M; Sarvi S; Sharif M; Daryani A
    Acta Parasitol; 2021 Sep; 66(3):733-744. PubMed ID: 33666861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis.
    Pappas G; Roussos N; Falagas ME
    Int J Parasitol; 2009 Oct; 39(12):1385-94. PubMed ID: 19433092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The global seroprevalence of Toxoplasma gondii among wild boars: A systematic review and meta-analysis.
    Rostami A; Riahi SM; Fakhri Y; Saber V; Hanifehpour H; Valizadeh S; Gholizadeh M; Pouya RH; Gamble HR
    Vet Parasitol; 2017 Sep; 244():12-20. PubMed ID: 28917302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global seroprevalence of
    Shariatzadeh SA; Sarvi S; Hosseini SA; Sharif M; Gholami S; Pagheh AS; Montazeri F; Nayeri T; Nakhaei M; Mikaeili Galeh T; Daryani A
    Parasitology; 2021 Oct; 148(12):1417-1433. PubMed ID: 34187606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis.
    Daryani A; Sarvi S; Aarabi M; Mizani A; Ahmadpour E; Shokri A; Rahimi MT; Sharif M
    Acta Trop; 2014 Sep; 137():185-94. PubMed ID: 24887263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in
    Yenilmez E; Çetinkaya RA
    Turkiye Parazitol Derg; 2019 Oct; 43(Suppl 1):1-7. PubMed ID: 31587535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global serological prevalence of Toxoplasma gondii in felids during the last five decades (1967-2017): a systematic review and meta-analysis.
    Montazeri M; Mikaeili Galeh T; Moosazadeh M; Sarvi S; Dodangeh S; Javidnia J; Sharif M; Daryani A
    Parasit Vectors; 2020 Feb; 13(1):82. PubMed ID: 32066495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review on the Prevalence of
    Nasiru Wana M; Mohd Moklas MA; Watanabe M; Nordin N; Zasmy Unyah N; Alhassan Abdullahi S; Ahmad Issa Alapid A; Mustapha T; Basir R; Abd Majid R
    Int J Environ Res Public Health; 2020 Jul; 17(13):. PubMed ID: 32635389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of Toxoplasma gondii infection in cancer patients: A systematic review and meta-analysis.
    Anvari D; Sharif M; Sarvi S; Aghayan SA; Gholami S; Pagheh AS; Hosseini SA; Saberi R; Chegeni TN; Hosseininejad Z; Daryani A
    Microb Pathog; 2019 Apr; 129():30-42. PubMed ID: 30708042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: A systematic review and meta-analysis.
    Foroutan-Rad M; Khademvatan S; Majidiani H; Aryamand S; Rahim F; Malehi AS
    Acta Trop; 2016 Jun; 158():160-169. PubMed ID: 26952970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Seroprevalence and risk factors of
    Xie YQ; He MZ; Zhang WH
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Jul; 32(6):635-639. PubMed ID: 33325201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Status of
    Galeh TM; Sarvi S; Montazeri M; Moosazadeh M; Nakhaei M; Shariatzadeh SA; Daryani A
    Front Vet Sci; 2020; 7():461. PubMed ID: 32851037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Toxoplasma gondii infection in Nigeria: a systematic review and meta-analysis of data published between 1960 and 2019.
    Karshima SN; Karshima MN
    BMC Public Health; 2020 Jun; 20(1):877. PubMed ID: 32505179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of Toxoplasma gondii infection in blood donors in mainland China: a systematic review and meta-analysis.
    Wang T; Han Y; Pan Z; Wang H; Yuan M; Lin H
    Parasite; 2018; 25():36. PubMed ID: 30040610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis.
    Wang ZD; Wang SC; Liu HH; Ma HY; Li ZY; Wei F; Zhu XQ; Liu Q
    Lancet HIV; 2017 Apr; 4(4):e177-e188. PubMed ID: 28159548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global seroprevalence of
    Bisetegn H; Debash H; Ebrahim H; Mahmood N; Gedefie A; Tilahun M; Alemayehu E; Mohammed O; Feleke DG
    Health Sci Rep; 2023 Jun; 6(6):e1319. PubMed ID: 37287705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review, meta-analysis and meta-regression of the global prevalence of Toxoplasma gondii infection in wild marine mammals and associations with epidemiological variables.
    Li MY; Gao XN; Ma JY; Elsheikha HM; Cong W
    Transbound Emerg Dis; 2022 Sep; 69(5):e1213-e1230. PubMed ID: 35195942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particularly neglected in countries with other challenges: High Toxoplasma gondii seroprevalence in pregnant women in Kabul, Afghanistan, while a low proportion know about the parasite.
    Mosawi SH; Zarghona Z; Dalimi A; Jokelainen P; Safa AH; Mohammadi MR; Javanmardi E; Basirat MB
    PLoS One; 2019; 14(10):e0223585. PubMed ID: 31600338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.